In vivo stability and metabolism of 99tcm-labelled anti-cd4 monoclonal antibodies and fab’ fragments

Nuclear Medicine Communications

Volumn 20, Issue 1, 1999, Pages 67-76

  Kinne, Raimund W ^a   Palombo Kinne, E ^a   Emmrich, F ^a   Schemer, K ^b   Wolf, F ^b   Behr, T ^c   Becker, W ^c   Sharkey, R M ^d   Goldenberg, D M ^d  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d Center of Molecular Medicine and Immunology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN DERIVATIVE; CYSTEINE; GLUTATHIONE; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; TECHNETIUM 99M;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; DRUG STABILITY; FEMALE; GEL FILTRATION CHROMATOGRAPHY; ISOTOPE LABELING; NONHUMAN; RAT; SCINTIGRAPHY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; ARTHRITIS, EXPERIMENTAL; CHROMATOGRAPHY, GEL; DRUG STABILITY; FEMALE; GAMMA CAMERAS; IMMUNOGLOBULIN FAB FRAGMENTS; ISOTOPE LABELING; JOINTS; RADIOPHARMACEUTICALS; RATS; RATS, INBRED LEW; SYNOVIAL MEMBRANE; TECHNETIUM COMPOUNDS;

EID: 0033012358     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-199901000-00011     Document Type: Article

References (23)

1. Becker W, Emmrich F, Horneff Get al. Imaging rheumatoid arthritis specifically with technetium 99m CD4-specific (T-helper lymphocytes) antibodies. Eur J Nucl Med 1990; 17: 156-159.
2. Kinne RW, Becker W, Schwab J et al. Comparison of ’relabeled specific murine anti-CD4 monoclonal antibodies and nonspecific human immunoglobulin for imaging of inflamed joints in rheumatoid arthritis. Nucl Med Commun 1993; 14: 667-675.
3. Kinne RW, Becker W, Schwab J et al. Imaging of rheumatoid arthritis joints with 99Tcm-labeled specific anti-CD4 and non-specific immunoglobulins: Case report. Eur J Nucl Med 1994; 21: 178-180.
4. Kinne RW, Becker W, Simon G et al. Joint uptake and body distribution of a technetium-99m-labeled anti-rat-CD4 monoclonal antibody in rat adjuvant arthritis. J Nucl Med 1993; 34: 92-98.
5. Kinne RW, Becker W, Koscheck et al. Rat adjuvant arthritis: Imaging with technetium-99m-anti-CD4 Fab’ fragments. J Nucl Med 1995; 36: 2268-2275.
6. Hansen HJ, Jones AL, Sharkey RM et al. Preclinical evaluation of an ’instant’ 99Tcm-labeling kit for antibody imaging. Cancer Res 1990; 50 (suppl): 794s-798s.
7. Kinne RW, Schmidt-Weber CB, Hoppe R et al. Long-term amelioration of rat adjuvant arthritis following systemic elimination of macrophages by clodronate-containing liposomes. Arthritis Rheum 1995; 38: 1777-1790.
8. Williams AF, Galfre G, Milstein C. Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: Differentiation antigens of rat lymphocytes. Cell 1977; 12: 663-668.
9. Behr T, Becker W, Hannappel E, Goldenberg DM, Wolf F. Targeting of liver metastases of colorectal cancer with IgG, F(ab’)2 and Fab’ anti-carcinoembryonic antigen antibodies labeled with 99Tcm: The role of metabolism and kinetics. Cancer Res 1995; 55 (suppl.): 5777s-5785s.
10. Behr T, Becker W, Hannappel E, Wolf F. Structural modifications of monoclonal antibodies following direct versus indirect labelling with 99Tcm: Does fragmentation really occur? Nucl Med Commun 1994; 15: 865-870.
11. Koscheck, I. Inaugural dissertation, Spezifische Darstellung entzündeter Gelenke in der Ratten-Adjuvans-Arthritis mit einem Technetium-99m markierten anti-CD4 Fab’-Frag-ment, Friedrich-Alexander-Universität Erlangen-Nürnberg, 25 April 1996.
12. Mardirossian G, Wu C, Ruschkowski M, Hnatowich DJ. The stability of technetium-99m directly labeled to a Fab’ antibody via stannous ion and mercaptoethanol reduction. Nucl Med Commun 1992; 13: 503-512.
13. Horneff G, Guse AH, Schulze-Koops H, Kalden JR, Burme-ster GR, Emmrich F. Human CD4-modulation in vivo induced by antibody-treatment. Clin Immunol Immunopa-thol 1993; 66: 80-90.
14. Morel P, Vincent C, Wijdenes J, Revillard D. Internalization and degradation of anti-CD4 monoclonal antibodies bound to human peripheral blood lymphocytes. Mol Immunol 1993; 30: 649-657.
15. Gel filtration, theory and practice. Pharmacia Fine Chemicals, Company publication.
16. Behr TM, Sharkey RM, Juweid ME et al. Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives. Cancer Res 1995; 55: 3825-3834.
17. Steinhausen M. Nierenfunktion, Wasser und Elektrolythaushalt. In: Steinhausen M, ed. Lehrbuch der vegetativen Physiologie. München: Bergmann Verlag, 1984: 230-278.
18. Gekle G, Von Bruchhausen F, Fuchs G. Über die Größe der Porenäquivalente in isolierten Basalmembranen der Rattennierenrinde. Pflügers Archiv 1966; 289: 180-190.
19. Dijoseph JF, Walter TL, Hartman DA, Carlson RP. Short communication: Kidney dysfunction in the arthritic rat. Int J Immunopharm 1993; 15: 933-941.
20. Franch MA, Moreno JJ, Castell M, Queralt J. Urinary N-acetyl-beta-D-glucosaminidase as a marker of renal injury in adjuvant arthritis. Res Exp Med (Berl) 1990; 190: 213-218.
21. Pimm MV, Rajput RS, Frier M, Gribben SJ. Anomalies in reduction-mediated technetium-99m-labelling of monoclonal antibodies. Eur J Nucl Med 1991; 18: 973-976.
22. Sakahara H, Saga T, Endo K et al. In vivo instability of reduction-mediated 99Tcm-labeled monoclonal antibody. Nucl Med Biol 1993; 20: 617-623.
23. Hnatowich DJ, Madirossian G, Ruschowski M, Fogarasi M, Virzi F, Winnard P Directly and indirectly technetium-99m-labeled antibodies: A comparison of in vitro and animal in vivo properties. J Nucl Med 1993; 34: 109-119.